Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Retrospective study of preoperative deep vein thrombosis risk factors in patients with colorectal cancer

ABSTRACT: Primary outcome(s): Preoperative prevalence of deep vein thrombosis

DISEASE(S): Colorectal Cancer

PROVIDER: 2648762 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Single-cell RNA sequencing on the vein wall of mouse deep vein thrombosis

Project description:Deep vein thrombosis (DVT) is a common clinical problem, but its cellular and molecular mechanisms remain incompletely understood. We performed single-cell RNA sequencing (scRNA-seq) on the vein wall of mouse inferior vena cava (IVC) ligation model of deep vein thrombosis (DVT), to analyze the transcriptomic changes in the vein wall during acute venous thrombosis.

2023-02-10 | GSE221978 | GEO

Predictive value of preoperative nutritional biochemical indicators on postoperative lower limb deep vein thrombosis in patients with colorectal cancer

Project description:Primary outcome(s): Deep vein thrombosis of the lower limbs Study Design: Sequential

| 39716 | ecrin-mdr-crc

Single-cell RNA sequencing on the vein wall of mouse deep vein thrombosis

Project description:Single-cell RNA sequencing on the vein wall of mouse deep vein thrombosis

| PRJNA916965 | ENA

Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer

Project description:The chemoprophylaxis of deep vein thrombosis (DVT) with subcutaneous low-molecular-weight heparin (enoxaparin) in the postoperative period of elective surgeries is already well established in the literature and in clinical practice. However, the use of this medication can have a financial impact on the patient and the parenteral presentation itself is associated with pain at the application site, which can make it difficult for patients to adhere.

| 2711239 | ecrin-mdr-crc

Integrated Landscape of Plasma Metabolism and Proteome for Post-traumatic Deep Vein Thrombosisasma Metabolism and Proteome for Post-traumatic Deep Vein Thrombosis

Project description:Deep vein thrombosis (DVT) is a leading cause of morbidity and mortality after trauma. Here, we integrate metabolomics and proteomics in up to 680 individuals with and without DVT after trauma (pt-DVT) to reveal the metabolic alterations and their function, and provide potential biomarkers. We carried out a nested case-control study design using a prospective cohort, which enrolled 680 Chinese Han subjects diagnosed with acute traumatic fractures at the Department of Trauma Surgery, Honghui Hospital (Xi’an, China) from October 2018 to October 2022. There were 183 subjects (DVT patients: N=96, Controls: N=87) were used for proteomics analysis.

2024-07-22 | PXD054131 |

CNV analysis of hepatocellular carcinoma with portal vein tumor thrombosis

Project description:Portal vein tumor thrombosis is a strong poor indication of HCC. Characterizing the molecular alterations of these metastatic HCCs is important for understanding the molecular mechanisms during HCC progression and metastasis. Previous genomic studies mainly focus on single molecular layer, such as gene expressions or exonic mutations. In this study, we systematically examined the copy number variation (CNV), DNA methylation, miRNA and transcriptome of matched adjacent normal tissues, primary tumors and PVTTs from 19 HCC patients. Based on the integrative multi-omics profiles, we established the molecular landscape of the metastatic HCCs and identified a set of the recurrent genomic alterations and candidate driver genes.

2017-02-17 | GSE77275 | GEO

A comparison between rivaroxaban and placebo for the prevention of deep vein thrombosis or pulmonary embolism afetr laparoscpic surgery for colorectal cancer after initial heparin prophylaxis

Project description:Primary objectives: To assess the efficacy and safety of postdischarge extended (3 weeks) antithrombotic prophylaxis with rivaroxaban compared to placebo after planned laparoscopic surgery for colorectal cancer in patients who had received antithrombotic prophylaxis with LMWH during the hospital stay for 7±2 days Primary endpoints: The primary study outcome is a composite of symptomatic objectively confirmed VTE, asymptomatic ultrasonography-confirmed DVT or VTE-related death at 28±2 days from planned laparoscopic surgery for colorectal cancer in patients randomized to rivaroxaban or placebo.Pulmonary embolism will be diagnosed in the presence of:- intraluminal filling defect at computed tomography angiography or pulmonary angiography- high probability perfusion defect at perfusion lung scan with mismatch area compared to chest X Ray.Deep vein thrombosis will be diagnosed in the presence of:- an uncompressible vein segment in the deep vein of the lower limbs as assessed by complete compression ultrasonography examination

| 2535176 | ecrin-mdr-crc

RNA-seq analysis of hepatocellular carcinoma with portal vein tumor thrombosis

2017-02-17 | GSE77509 | GEO